The determination of busulphan in dissolution samples by flow injection analysis
被引:4
作者:
Dow, AD
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, England
Dow, AD
[1
]
Finlay, G
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, England
Finlay, G
[1
]
Bloomfield, MS
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, England
Bloomfield, MS
[1
]
机构:
[1] Glaxo Wellcome Res & Dev Ltd, Pharmaceut Dev, Ware SG12 0DP, Herts, England
A robust colourimetric dow injection analysis (FIA) procedure is described for the determination of busulphan in dissolution samples of a 2 mg tablet formulation. The sample solution is injected directly into a reagent stream containing 4-(4-nitrobenzyl)pyridine/potassium hydrogen phthalate. An on-line heating stage allows the formation of a coloured pyrridinium salt species, which following stabilisation is detected spectrophotometrically at 570 nm. The method has been fully validated and is linear over the concentration range 0.004-0.024 mg of busulphan ml(-1). The method can also been applied to uniformity of content and bulk assay testing. (C) 1999 Elsevier Science B.V. All rights reserved.